3 Receptors for plasminogen and t-PA: an update

Adelman, 1988, Plasminogen interactions with platelets in plasma, Blood, 72, 1530, 10.1182/blood.V72.5.1530.1530 Ahern, 1990, Site-directed mutagenesis in human tissue-plasminogen activator. Distinguishing sites in the amino-terminal region required for full fibrinolytic activity and rapid clearance from the circulation, Journal of Biological Chemistry, 265, 5540, 10.1016/S0021-9258(19)39394-9 Andreasen, 1994, Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes, Federation of European Biochemical Societies, 338, 239, 10.1016/0014-5793(94)80276-9 Bassel-Duby, 1992, Tyrosine 67 in the epidermal growth factor-like domain of tissue-type plasminogen activator is important for clearance by a specific hepatic receptor, Journal of Biological Chemistry, 267, 9668, 10.1016/S0021-9258(19)50142-9 Bauer, 1984, Interaction of plasmin with endothelial cells, Biochemical Journal, 218, 119, 10.1042/bj2180119 Becquemont, 1994, Expression of plasminogen/plasmin receptors on human glomerular epithelial cells, American Journal of Physiology/Renal, Fluid Electrolyte Physiology, 267, F303, 10.1152/ajprenal.1994.267.2.F303 Beebe, 1987, Binding of tissue plasminogen activator to human umbilical vein endothelial cells, Thrombosis Research, 46, 241, 10.1016/0049-3848(87)90286-6 Beebe, 1989, A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor, Blood, 74, 2034, 10.1182/blood.V74.6.2034.2034 Beebe, 1990, Characterization of tissue plasminogen activator binding proteins isolated from endothelial cells and other cell types, Thrombosis Research, 59, 339, 10.1016/0049-3848(90)90136-Z Berge, 1993, PAM, a novel plasminogen-binding protein from Streptococcus pyogenes, Journal of Biological Chemistry, 268, 25417, 10.1016/S0021-9258(19)74408-1 Browne, 1988, A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain, Journal of Biological Chemistry, 263, 1599, 10.1016/S0021-9258(19)77918-6 Browne, 1990, Deletion of a tripeptide sequence from the growth-factor domain of tissue-type plasminogen activator prolongs in vivo circulation, Thrombosis Research, 59, 687, 10.1016/0049-3848(90)90429-G Bu, 1993, Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells, Journal of Biological Chemistry, 268, 13002, 10.1016/S0021-9258(18)31486-8 Burtin, 1987, The plasmin system in human adenocarcinomas and their metastases. A comparative immunofluorescence study, International Journal of Cancer, 39, 170, 10.1002/ijc.2910390208 Burtin, 1988, Receptor for plasmin on human carcinoma cells, Journal of the National Cancer Institute, 80, 764, 10.1093/jnci/80.10.762 Camani, 1994, The role of plasminogen activator inhibitor type 1 in the clearance of tissue-type plasminogen activator by rat hepatoma cells, Journal of Biological Chemistry, 269, 5770, 10.1016/S0021-9258(17)37528-2 Cesarman, 1994, An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation, Journal of Biological Chemistry, 269, 21198, 10.1016/S0021-9258(17)31948-8 Collen, 1988, Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits, Blood, 71, 216, 10.1182/blood.V71.1.216.216 Conforti, 1994, Cell-surface plasminogen activation causes a retraction of in vitro cultured human umbilical vein endothelial cell monolayer, Blood, 83, 994, 10.1182/blood.V83.4.994.994 Correc, 1990, A comparative study of the localization of plasminogen and apolipoprotein(a) in human carcinomas, Thrombosis Research, 58, 213, 10.1016/0049-3848(90)90091-P Correc, 1990, The presence of plasmin receptors on three mammary carcinoma MCF-7 sublines, International Journal of Cancer, 46, 745, 10.1002/ijc.2910460432 Deguchi, 1985, The potentiating effect of platelet on plasminogen activation by tissue plasminogen activator, Thrombosis Research, 40, 853, 10.1016/0049-3848(85)90321-4 Dudani, 1991, Identification of an endothelial cell surface protein that binds plasminogen, Molecular and Cellular Biochemistry, 108, 133, 10.1007/BF00233117 Duval-Jobe, 1994, Regulation of plasminogen activation by human U937 promonocytic cells, Journal of Biological Chemistry, 269, 21353, 10.1016/S0021-9258(17)31969-5 Einarsson, 1988, Uptake and degradation of tissue plasminogen activator in rat liver, Thrombosis and Haemostasis, 59, 474, 10.1055/s-0038-1647518 Ellis, 1991, Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor, Journal of Biological Chemistry, 266, 12752, 10.1016/S0021-9258(18)98963-5 Felez, 1991, Binding of tissue plasminogen activator to human monocytes and monocytoid cells, Blood, 78, 2318, 10.1182/blood.V78.9.2318.2318 Felez, 1993, Competition between plasminogen and t-PA for cellular binding sites, Blood, 82, 2433, 10.1182/blood.V82.8.2433.2433 Felez, 1993, Receptor occupancy by plasminogen enhances its activation by t-PA (Abstract), Thrombosis and Haemostasis, 69, 1232 Fukao, 1992, Analysis of binding protein for tissue-type plasminogen activator in human endothelial cells, Biochemical and Biophysical Research Communications, 187, 956, 10.1016/0006-291X(92)91290-7 Gonias, 1989, Plasminogen binding to rat hepatocytes in primary culture and to thin slices of rat liver, Blood, 75, 729, 10.1182/blood.V74.2.729.729 Gonzalez-Gronow, 1989, Further characterization of the cellular plasminogen binding site: Evidence that plasminogen and lipoprotein(a) compete for the same site, Biochemistry, 28, 2374, 10.1021/bi00432a005 Gonzalez-Gronow, 1991, Plasmin binding to the plasminogen receptor enhances catalytic efficiency and activates the receptor for subsequent ligand binding, Archives of Biochemistry and Biophysics, 286, 625, 10.1016/0003-9861(91)90090-6 Gonzalez-Gronow, 1994, Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts, Journal of Biological Chemistry, 269, 4360, 10.1016/S0021-9258(17)41788-1 Hajjar, 1991, The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen, Journal of Biological Chemistry, 266, 21962, 10.1016/S0021-9258(18)54731-1 Hajjar, 1990, Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase, Journal of Biological Chemistry, 265, 2908, 10.1016/S0021-9258(19)39887-4 Hajjar, 1994, α-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells, Journal of Clinical Investigation, 93, 703, 10.1172/JCI117023 Hajjar, 1986, Binding of plasminogen to cultured human endothelial cells, Journal of Biological Chemistry, 261, 11656, 10.1016/S0021-9258(18)67293-X Hajjar, 1987, Binding of tissue plasminogen activator to cultured human endothelial cells, Journal of Clinical Investigation, 80, 1712, 10.1172/JCI113262 Hajjar, 1994, An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. identity with annexin II, Journal of Biological Chemistry, 269, 21191, 10.1016/S0021-9258(17)31947-6 Hall, 1989, Binding of bovine, ovine, porcine, canine, and rat plasminogen to rat hepatocytes and rat C6 glioma cells in vitro, Biochemical and Biophysical Research Communications, 164, 1288, 10.1016/0006-291X(89)91809-3 Hall, 1990, Plasminogen carbohydrate side chains in receptor binding and enzyme activation: A study of C6 Glioma cells and primary cultures of rat hepatocytes, Journal of Cellular Biochemistry, 43, 213, 10.1002/jcb.240430303 Hall, 1991, Inhibition of cell surface receptor-bound plasmin by α2-antiplasmin and α2-macroglobulin, Journal of Biological Chemistry, 266, 12329, 10.1016/S0021-9258(18)98900-3 Harris, 1991, Tissue plasminogen activator has an O-linked fucose attached to threonine-61 in the epidermal growth factor domain, Biochemical Journal, 30, 2311, 10.1021/bi00223a004 Hotchkiss, 1988, The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator, Thrombosis and Haemostasis, 60, 255, 10.1055/s-0038-1647041 Ikenada, 1992, Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain, Blood Coagulation and Fibrinolysis, 3, 381, 10.1097/00001721-199208000-00004 Kuiper, 1988, Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells, Journal of Biological Chemistry, 263, 18220, 10.1016/S0021-9258(19)81348-0 Lijnen, 1990, On the molecular interactions between fibrin, tissue-type plasminogen activator and plasminogen, Thrombosis Research, 57, 45, 10.1016/0049-3848(90)90377-O Lo, 1989, Role of catalytic and Iysine-binding sites in plasmin-induced neutrophil adherence to endothelium, Journal of Clinical Investigation, 84, 793, 10.1172/JCI114238 Lottenberg, 1992, Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor, Journal of Bacteriology, 174, 5204, 10.1128/jb.174.16.5204-5210.1992 Lu, 1988, Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells, Biochemical and Biophysical Research Communications, 155, 418, 10.1016/S0006-291X(88)81102-1 Merenmies, 1991, 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane, Journal of Biological Chemistry, 266, 16722, 10.1016/S0021-9258(18)55361-8 Miles, 1985, Binding and activation of plasminogen on the platelet surface, Journal of Biological Chemistry, 260, 4303, 10.1016/S0021-9258(18)89264-X Miles, 1987, Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells, Thrombosis and Haemostasis, 58, 936, 10.1055/s-0038-1646019 Miles, 1988, Plasminogen receptors: Ubiquitous sites for cellular regulation of fibrinolysis, Fibrinolysis, 2, 61, 10.1016/0268-9499(88)90369-4 Miles, 1986, Plasminogen interacts with human platelets through two distinct mechanisms, Journal of Clinical Investigation, 77, 2001, 10.1172/JCI112529 Miles, 1988, The cell-binding domains of plasminogen and their function in plasma, Journal of Biological Chemistry, 263, 11928, 10.1016/S0021-9258(18)37875-X Miles, 1988, Plasminogen receptors, urokinase receptors, and their modulation on human endothelial cells, Blood, 72, 628, 10.1182/blood.V72.2.628.628 Miles, 1989, Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells, Biochemistry, 28, 9337, 10.1021/bi00450a014 Miles, 1991, Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor, Biochemistry, 30, 1682, 10.1021/bi00220a034 Morton, 1989, Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2: modulation by plasminogen inhibitor type 1, Journal of Biological Chemistry, 264, 7228, 10.1016/S0021-9258(18)83225-2 Murata, 1991, Extracellular and cell-associated localizations of plasminogen activators and plasminogen activator inhibitor-1 in cultured endothelium, Experimental and Molecular Pathology, 55, 105, 10.1016/0014-4800(91)90046-Z Nakajima, 1993, Plasminogen-binding protein associated with the plasma membrane of cultured embryonic rat neocortical neurons, Federation of European Biochemical Societies, 333, 223, 10.1016/0014-5793(93)80658-H Nakajima, 1994, Plasminogen mediates an interaction between microglia and dopaminergic neurons, European Neurology, 34, 10, 10.1159/000119536 Orth, 1992, Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor, 89, 7422 Orth, 1994, Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator, Journal of Biological Chemistry, 269, 21117, 10.1016/S0021-9258(17)31937-3 Otter, 1991, Binding of tissue-type plasminogen activator by the mannose receptor, Journal of Biological Chemistry, 266, 13931, 10.1016/S0021-9258(18)92791-2 Otter, 1992, Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA, Biochemical Journal, 284, 545, 10.1042/bj2840545 Otter, 1992, Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liver, Annals of the New York Academy of Sciences, 667, 431, 10.1111/j.1749-6632.1992.tb51645.x Otter, 1992, Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator, Hepatology, 16, 54, 10.1002/hep.1840160111 Parkkinen, 1991, Interactions of plasminogen and tissue plasminogen activated (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin, Journal of Biological Chemistry, 266, 16730, 10.1016/S0021-9258(18)55362-X Parkkinen, 1993, Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation, Journal of Biological Chemistry, 268, 19726, 10.1016/S0021-9258(19)36575-5 Pittman, 1989, Neuronal plasminogen activators: Cell surface binding sites and involvement in neurite outgrowth, Journal of Neuroscience, 9, 4269, 10.1523/JNEUROSCI.09-12-04269.1989 Plow, 1990, Plasminogen receptors in the mediation of pericellular proteolysis, Cell Differentiation and Development, 32, 293, 10.1016/0922-3371(90)90042-U Plow, 1986, The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type, Journal of Cell Biology, 103, 2411, 10.1083/jcb.103.6.2411 Redlitz, 1995, The role of an elolase-related molecule in plasminogen binding to cells, European Journal of Biochemistry, 227, 407, 10.1111/j.1432-1033.1995.tb20403.x Rijken, 1986, Clearance of the heavy and light polypeptide chains of human tissue-type plasminogen activator in rats, Biochemistry Journal, 238, 643, 10.1042/bj2380643 Rutilant, 1993, 15, 97 Ryan, 1992, Plasmin generation induces neutrophil aggregation: Dependence on the catalytic and lysine binding sites, Journal of Cellular Physiology, 151, 255, 10.1002/jcp.1041510206 Sakata, 1988, Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells, Journal of Biological Chemistry, 263, 1960, 10.1016/S0021-9258(19)77972-1 Sanzo, 1990, Binding of tissue plasminogen activator to human aortic endothelial cells, Biochemical Journal, 269, 475, 10.1042/bj2690475 Schleef, 1990, The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator, Journal of Cell Biology, 110, 155, 10.1083/jcb.110.1.155 Silverstein, 1988, Binding of lys-plasminogen to monocytes/macrophages, Journal of Clinical Investigation, 82, 1948, 10.1172/JCI113814 Smedsrod, 1988, Tissue plasminogen activator is endocytosed by mannose and galactose receptors of rat liver cells, Thrombosis and Haemostasis, 59, 480, 10.1055/s-0038-1647519 Stricker, 1986, Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation, Blood, 68, 275, 10.1182/blood.V68.1.275.275 Takada, 1988, Physiology of plasminogen: With special reference to activation and degradation, Haemostasis, 18, 25 Vassalli, 1985, A cellular binding site for the M, 55,000 form of the human plasminogen activator, urokinase, Journal of Cellular Biology, 100, 86, 10.1083/jcb.100.1.86 Vassalli, 1991, The plasminogen activator/plasmin system, Journal of Clinical Investigation, 88, 1067, 10.1172/JCI115405 Vaughan, 1989, Characterization of the binding of human tissue-type plasminogen activator to platelets, Journal of Biological Chemistry, 264, 15869, 10.1016/S0021-9258(18)71558-5 Verrall, 1989, Characterization of 125I-tissue plasminogen activator binding to cerebellar granule neurons, Journal of Cell Biology, 109, 265, 10.1083/jcb.109.1.265 Warshawsky, 1993, 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo, Journal of Clinical Investigation, 92, 937, 10.1172/JCI116669 Willnow, 1992, Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance, Journal of Biological Chemistry, 267, 26172, 10.1016/S0021-9258(18)35732-6 Wing, 1991, The receptor for tissue plasminogen activator (t-PA) in complex with its inhibitor, PAI-1, on human hepatocytes, Federation of European Biochemical Societies, 278, 95, 10.1016/0014-5793(91)80092-H Yahara, 1992, Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the finger domain, Thrombosis and Haemostasis, 68, 672, 10.1055/s-0038-1646342 Yahara, 1994, Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions between positions 37 and 42, Fibrinolysis, 8, 286, 10.1016/0268-9499(94)90017-5